Technical Analysis for VBLT - Vascular Biogenics Ltd.

Grade Last Price % Change Price Change
grade D 1.15 -5.74% -0.07
VBLT closed down 5.74 percent on Friday, January 18, 2019, on 63 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Flat
See historical VBLT trend table...

Date Alert Name Type % Chg
Jan 18 Bearish Engulfing Bearish 0.00%
Jan 18 Stochastic Sell Signal Bearish 0.00%
Jan 18 Outside Day Range Expansion 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Narrow Range Bar Range Contraction -5.74%
Jan 17 NR7 Range Contraction -5.74%
Jan 17 Wide Bands Range Expansion -5.74%
Jan 17 Overbought Stochastic Strength -5.74%
Jan 16 Wide Bands Range Expansion -4.17%

Older signals for VBLT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
Is VBLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.6
52 Week Low 0.6
Average Volume 144,834
200-Day Moving Average 1.7404
50-Day Moving Average 1.1185
20-Day Moving Average 1.0155
10-Day Moving Average 1.154
Average True Range 0.099
ADX 23.95
+DI 18.5292
-DI 14.6861
Chandelier Exit (Long, 3 ATRs ) 0.953
Chandelier Exit (Short, 3 ATRs ) 0.897
Upper Bollinger Band 1.3487
Lower Bollinger Band 0.6823
Percent B (%b) 0.7
BandWidth 65.622846
MACD Line 0.0261
MACD Signal Line -0.002
MACD Histogram 0.028
Fundamentals Value
Market Cap 31.06 Million
Num Shares 27 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -1.72
Price-to-Sales 0.00
Price-to-Book 4.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.30
Resistance 3 (R3) 1.32 1.28 1.28
Resistance 2 (R2) 1.28 1.25 1.28 1.27
Resistance 1 (R1) 1.22 1.22 1.20 1.20 1.26
Pivot Point 1.18 1.18 1.18 1.18 1.18
Support 1 (S1) 1.12 1.15 1.10 1.10 1.04
Support 2 (S2) 1.08 1.12 1.08 1.03
Support 3 (S3) 1.02 1.08 1.03
Support 4 (S4) 1.00